San Diego, CA, United States of America

Vidyasagar Gantla

USPTO Granted Patents = 6 

Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Inventor Vidyasagar Gantla

Introduction

Vidyasagar Gantla is an accomplished inventor based in San Diego, California. With a total of five patents to his name, he has made significant contributions to the field of medicinal chemistry, particularly in the treatment of filovirus infections.

Latest Patents

Among his notable inventions are two recent patents focused on adamantane derivatives. The first patent pertains to "Adamantane derivatives for the treatment of filovirus infection", where the compounds of structural Formula I are specifically designed to combat infections by filoviruses, including Ebolavirus and Marburgvirus. The second patent, titled "Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection", details compounds that are also effective against these viral infections.

Career Highlights

Throughout his career, Gantla has held positions at prominent firms in the pharmaceutical industry, including Arisan Therapeutics Inc. and Chembridge Corporation. His work at these companies has allowed him to engage in groundbreaking research and development in the fight against significant health threats posed by filoviruses.

Collaborations

Vidyasagar has collaborated with distinguished professionals in his field, including Michael Bruno Plewe and Eric Brown. These collaborations have helped enhance his research efforts and have contributed to his success as an inventor.

Conclusion

In conclusion, Vidyasagar Gantla stands out as a noteworthy inventor with impactful contributions to medical science through his innovative patents. His work provides promising avenues for treatment options against formidable viral infections, underscoring the importance of continued research and innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…